Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

PROCEPT BioRobotics (PRCT) Leases (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Leases for 6 consecutive years, with $17.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases fell 7.41% to $17.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.5 million, a 7.41% decrease, with the full-year FY2025 number at $17.5 million, down 7.41% from a year prior.
  • Leases was $17.5 million for Q4 2025 at PROCEPT BioRobotics, down from $17.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $24.4 million in Q3 2022 to a low of $2.5 million in Q2 2022.
  • A 5-year average of $16.4 million and a median of $19.1 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: dropped 29.35% in 2021, then surged 775.48% in 2023.
  • PROCEPT BioRobotics' Leases stood at $3.3 million in 2021, then soared by 592.28% to $22.7 million in 2022, then dropped by 10.83% to $20.2 million in 2023, then decreased by 6.42% to $18.9 million in 2024, then decreased by 7.41% to $17.5 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Leases are $17.5 million (Q4 2025), $17.9 million (Q3 2025), and $18.3 million (Q2 2025).